Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723): Difference between revisions
From MaRDI portal
Set profile property. |
Set OpenAlex properties. |
||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1007/s11166-008-9032-2 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2008346906 / rank | |||
Normal rank | |||
Revision as of 00:23, 20 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks |
scientific article |
Statements
Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (English)
0 references
11 June 2008
0 references
Value of statistical life
0 references
Cancer risk
0 references
Risk trade-off
0 references
Latency
0 references
